FLUNIXIN MEGLUMINE powder

País: Estados Unidos

Língua: inglês

Origem: NLM (National Library of Medicine)

Ingredientes ativos:

FLUNIXIN MEGLUMINE (UNII: 8Y3JK0JW3U) (FLUNIXIN - UNII:356IB1O400)

Disponível em:

Qilu SYNVA Pharmaceutical Co., Ltd.

Via de administração:

NOT APPLICABLE

Tipo de prescrição:

BULK INGREDIENT -

Status de autorização:

bulk ingredient

Características técnicas

FLUNIXIN MEGLUMINE- FLUNIXIN MEGLUMINE POWDER
QILU SYNVA PHARMACEUTICAL CO., LTD.
----------
FLUNIXIN MEGLUMINE
flunixin meglumine powder
PRODUCT INFORMATION
PRODUCT TYPE
ITEM CODE (SOURCE)
NDC:49553-4661
ROUTE OF ADMINISTRATION
NOT APPLICABLE
ACTIVE INGREDIENT/ACTIVE MOIETY
INGREDIENT NAME
BASIS OF STRENGTH
STRENGTH
FLUNIXIN MEGLUMINE (UNII: 8Y3JK0JW3U) (FLUNIXIN - UNII:356IB1O400)
FLUNIXIN MEGLUMINE
25 kg in 25 kg
PACKAGING
#
ITEM CODE
PACKAGE DESCRIPTION
MARKETING START DATE
MARKETING END DATE
1 NDC:49553-4661-1
25 kg in 1 DRUM
Qilu SYNVA Pharmaceutical Co., Ltd.
MARKETING INFORMATION
MARKETING
CATEGORY
APPLICATION NUMBER OR MONOGRAPH
CITATION
MARKETING START
DATE
MARKETING END
DATE
bulk ingredient
12/16/2021
LABELER -
Qilu SYNVA Pharmaceutical Co., Ltd. (421272539)
ESTABLISHMENT
NAME
ADDRESS
ID/FEI
BUSINESS OPERATIONS
Qilu SYNVA Pharmaceutical Co., Ltd.
421272539
api manufacture
Revised: 12/2021